Ossai David O, Yoade Bolaji, Busari Oluwatoyin, Agwu Princess, Adewoye Tinuoye, Kalle Fanta, Agwu Rosemary, Atolagbe Ayodele, Nkemjika Stanley
Department of Public Health, Georgia State University, Atlanta, USA.
Psychiatry and Behavioral Sciences, Interfaith Medical Center, Brooklyn, USA.
Cureus. 2024 Feb 25;16(2):e54885. doi: 10.7759/cureus.54885. eCollection 2024 Feb.
Methamphetamine use disorder (MUD) is becoming more of a public health issue in Georgia State, with health and social effects affecting both people and communities. This study aimed to investigate attributes that may affect the accessibility of treatment among the methamphetamine-use population in the state of Georgia.
We utilized the Treatment Episode Data Set - Discharges (TEDS-D) for 2016-2020 in Georgia, comprising participants with MUD (175,270). We utilized descriptive statistics and inferential techniques to ascertain the relationship between variables. Multiple logistic regression was used to control for confounding variables at a 95% confidence interval.
This study's findings showed individuals aged 25-49 years had 1.8 times higher odds of getting treatment for methamphetamine use compared to those aged 12-24 years (adjusted odds ratio (AOR) = 1.8; 95% CI: 1.50-2.16). Alaska Native individuals (Aleut, Eskimo, and Indian) had 7.07 times higher odds of receiving treatment than Asian or Pacific Islander individuals (AOR = 7.07; 95% CI: 2.02-24.67). Compared to Asian or Pacific Islander individuals, Black or African American individuals had 12.11 times higher odds of receiving treatment (AOR = 12.11; 95% CI: 9.37-15.66), while White individuals had 6.82 times higher odds of getting treatment (AOR = 1.09; 95% CI: 0.86-1.37).
MUD treatment disparity challenges are revealed in our study, emphasizing the critical need for focused intervention programs.
甲基苯丙胺使用障碍(MUD)在佐治亚州正日益成为一个公共卫生问题,其对健康和社会的影响波及个人与社区。本研究旨在调查可能影响佐治亚州甲基苯丙胺使用人群获得治疗机会的因素。
我们使用了佐治亚州2016 - 2020年的治疗事件数据集 - 出院数据(TEDS - D),其中包括患有MUD的参与者(175,270人)。我们运用描述性统计和推断技术来确定变量之间的关系。采用多元逻辑回归在95%置信区间控制混杂变量。
本研究结果显示,25 - 49岁的个体接受甲基苯丙胺使用治疗的几率比12 - 24岁的个体高1.8倍(调整后的优势比(AOR)= 1.8;95%置信区间:1.50 - 2.16)。阿拉斯加原住民(阿留申人、爱斯基摩人和印第安人)接受治疗的几率比亚洲或太平洋岛民个体高7.07倍(AOR = 7.07;95%置信区间:2.02 - 24.67)。与亚洲或太平洋岛民个体相比,黑人或非裔美国人接受治疗的几率高12.11倍(AOR = 12.11;95%置信区间:9.37 - 15.66),而白人接受治疗的几率高6.82倍(AOR = 1.09;95%置信区间:0.86 - 1.37)。
我们的研究揭示了MUD治疗差异方面的挑战,强调了针对性干预项目的迫切需求。